Bermaz Motor has successfully raised RM303,000 for the Mazda Medicare Fund (MMF) with the support of generous golfers and donors competing in the 6th Mazda Charity Golf Tournament held at the Sultan Abdul Aziz Shah Golf & Country Club (SAASGCC) in Shah Alam.
Bermaz expresses their gratitude and heartfelt thanks for the unwavering support that Mazda owners, Mazda dealers and Bermaz business partners have given to the MMF initiative in its mission to help those in need.
Earlier this year, the Mazda Privilege Card was launched in collaboration with the MMF where all sign-up fees serve as funds donated by Mazda owners. The introduction of the card has been received with heart-warming support for its noble cause. Donations to the MMF have since continued to increase rapidly thanks to the benevolent contributions of social responsibility conscious Mazda owners who continues to engage with Bermaz Motor through various charitable programmes.
The MMF was initiated with the objective of providing life-saving haemodialysis treatment for end-stage renal disease (ESRD) patients with financial constraints. Eligible patients would receive subsidized haemodialysis treatments at any one of B. Braun’s dialysis centres operating in Malaysia.
While the MMF’s primary objective is to provide medical assistance to those in need, it also provides financial support to charitable homes. Charitable homes are carefully selected and vetted by the MMF Team in order to ensure that all donations are put to good use. The MMF Team consists of Bermaz volunteer employees; therefore there are no additional costs involved in MMF’s operations. This will allow all donations received to go where it really matters – to the people in need.
With the continuous support that the MMF has been receiving, Bermaz is now able to further develop the extent of MMF’s reach. In line with the MMF’s objective to provide medical assistance, Bermaz is now exploring and establishing a framework for healthcare campaign that will focus on raising awareness, prevention and early detection of terminal diseases.
